Actuate Therapeutics IncACTUNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank67
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-20.42M
Near historical average
Percentile
P67
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-20.42M
Historical baseline
PeriodValueYoY Change
TTM$-20.42M+6.5%
2024$-21.84M-1.0%
2023$-21.63M-21.5%
2022$-17.79M-